Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm (TACE-RFA)

This study has been completed.
Information provided by Shandong University

Please refer to this study by its ClinicalTrials.gov identifier: NCT00479050

Sponsors and Collaborators

Shandong University

Investigators


Study Chair:	Wang Qi Liang, MD,PhD	Dept of radiology